Pennsylvania Court Determines Insurance Reimbursement for Medical Marijuana Does Not Violate Federal Law
4/30/2023
On March 17, 2023, a Pennsylvania Commonwealth Court held that an employee was entitled to reimbursement for medical marijuana as recommended and deemed necessary by his physician under the state Workers’ Compensation Act.
The decision is significant because the court addressed the conflict between Pennsylvania’s Medical Marijuana Act (MMA), which recognizes medical marijuana as a bona fide medical treatment for several conditions, and the federal Controlled Substances Act (Federal Drug Act), which prohibits any use of or payment for marijuana. The court’s majority found that providing reimbursement for treatment prescribed by a physician under the provisions of the MMA would not cause the insurer to “manufacture, distribute, or dispense” a controlled substance and, therefore, did not violate federal law.
Related Practices: Healthcare Law
Related Attorney: John D. Fanburg, Riza I. Dagli
Related Industry: Healthcare